These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 31866182

  • 1. Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.
    Freyer DR, Brock PR, Chang KW, Dupuis LL, Epelman S, Knight K, Mills D, Phillips R, Potter E, Risby D, Simpkin P, Sullivan M, Cabral S, Robinson PD, Sung L.
    Lancet Child Adolesc Health; 2020 Feb; 4(2):141-150. PubMed ID: 31866182
    [Abstract] [Full Text] [Related]

  • 2. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2014 Jul 01; (7):CD009219. PubMed ID: 24984156
    [Abstract] [Full Text] [Related]

  • 3. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD009219. PubMed ID: 22592737
    [Abstract] [Full Text] [Related]

  • 4. Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
    Freyer DR, Brock P, Knight K, Reaman G, Cabral S, Robinson PD, Sung L.
    Lancet Child Adolesc Health; 2019 Aug 16; 3(8):578-584. PubMed ID: 31160205
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey.
    Orgel E, Freyer DR, Ullrich NJ, Hardy KK, Thomas SM, Dvorak CC, Esbenshade AJ.
    Pediatr Blood Cancer; 2020 Nov 16; 67(11):e28647. PubMed ID: 32886425
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
    Brock PR, Maibach R, Childs M, Rajput K, Roebuck D, Sullivan MJ, Laithier V, Ronghe M, Dall'Igna P, Hiyama E, Brichard B, Skeen J, Mateos ME, Capra M, Rangaswami AA, Ansari M, Rechnitzer C, Veal GJ, Covezzoli A, Brugières L, Perilongo G, Czauderna P, Morland B, Neuwelt EA.
    N Engl J Med; 2018 Jun 21; 378(25):2376-2385. PubMed ID: 29924955
    [Abstract] [Full Text] [Related]

  • 9. Prevention of cisplatin-induced hearing-loss by sodium thiosulfate in medulloblastoma.
    Harao T, Yamada A, Kinoshita M, Kamimura S, Moritake H.
    Pediatr Int; 2020 Oct 21; 62(10):1204-1206. PubMed ID: 32989850
    [No Abstract] [Full Text] [Related]

  • 10. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
    Rolland V, Meyer F, Guitton MJ, Bussières R, Philippon D, Bairati I, Leclerc M, Côté M.
    J Otolaryngol Head Neck Surg; 2019 Jan 16; 48(1):4. PubMed ID: 30651130
    [Abstract] [Full Text] [Related]

  • 11. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2016 Aug 08; (8):CD010885. PubMed ID: 27498707
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platinum-induced hearing loss after treatment for childhood cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2016 Aug 03; 2016(8):CD010181. PubMed ID: 27486906
    [Abstract] [Full Text] [Related]

  • 14. Hepatoblastoma, cisplatin, and ototoxicity: good news on deaf ears.
    Sullivan MJ.
    Cancer; 2009 Dec 15; 115(24):5623-6. PubMed ID: 19813276
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention and treatment of cisplatin-induced ototoxicity in adults: A systematic review.
    Correa-Morales JE, Giraldo-Moreno S, Mantilla-Manosalva N, Cuellar-Valencia L, Borja-Montes OF, Bedoya-Muñoz LJ, Iriarte-Aristizábal MF, Quintero-Muñoz E, Zuluaga-Liberato AM.
    Clin Otolaryngol; 2024 Jan 15; 49(1):1-15. PubMed ID: 37818931
    [Abstract] [Full Text] [Related]

  • 18. [Sodium thiosulfate in preventing ototoxicity associated with cisplatin in pediatric patients with localized, non-metastatic solid tumors].
    Saillant A, Campedel L.
    Bull Cancer; 2024 Feb 15; 111(2):129-130. PubMed ID: 38092636
    [No Abstract] [Full Text] [Related]

  • 19. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
    Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT.
    Arch Otolaryngol Head Neck Surg; 1997 Sep 15; 123(9):978-81. PubMed ID: 9305250
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.